Brian A. Lanman

4.3k total citations
25 papers, 506 citations indexed

About

Brian A. Lanman is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Brian A. Lanman has authored 25 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Brian A. Lanman's work include Ubiquitin and proteasome pathways (6 papers), Synthetic Organic Chemistry Methods (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Brian A. Lanman is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Synthetic Organic Chemistry Methods (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). Brian A. Lanman collaborates with scholars based in United States, Denmark and India. Brian A. Lanman's co-authors include Andrew G. Myers, Larry E. Overman, Boyu Zhong, Daniel W. Kung, Soojin Kwon, Mohammad Movassaghi, Andrew T. Parsons, Stephan G. Zech, Ralph Paulini and Victor J. Cee and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Accounts of Chemical Research.

In The Last Decade

Brian A. Lanman

24 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian A. Lanman United States 12 367 221 59 55 42 25 506
Paul A. Renhowe United States 18 617 1.7× 412 1.9× 76 1.3× 56 1.0× 83 2.0× 26 891
Stephen T. Wrobleski United States 13 384 1.0× 196 0.9× 68 1.2× 86 1.6× 37 0.9× 16 555
Michaël Prakesch Canada 15 324 0.9× 287 1.3× 21 0.4× 48 0.9× 64 1.5× 25 609
Les A. Dakin United States 16 560 1.5× 188 0.9× 56 0.9× 34 0.6× 69 1.6× 25 729
Ana Belén Garcı́a Spain 14 688 1.9× 375 1.7× 36 0.6× 70 1.3× 28 0.7× 23 832
Tina M. Morwick United States 14 407 1.1× 158 0.7× 35 0.6× 31 0.6× 66 1.6× 23 564
Darin J. Gustin United States 15 253 0.7× 267 1.2× 31 0.5× 133 2.4× 77 1.8× 20 548
Naresh K. Chadha United States 11 420 1.1× 172 0.8× 25 0.4× 41 0.7× 37 0.9× 14 546
Matthew A. Marx United States 13 378 1.0× 342 1.5× 16 0.3× 41 0.7× 66 1.6× 40 632
Hong-Yong Kim South Korea 14 236 0.6× 203 0.9× 34 0.6× 30 0.5× 124 3.0× 19 484

Countries citing papers authored by Brian A. Lanman

Since Specialization
Citations

This map shows the geographic impact of Brian A. Lanman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Lanman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Lanman more than expected).

Fields of papers citing papers by Brian A. Lanman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Lanman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Lanman. The network helps show where Brian A. Lanman may publish in the future.

Co-authorship network of co-authors of Brian A. Lanman

This figure shows the co-authorship network connecting the top 25 collaborators of Brian A. Lanman. A scholar is included among the top collaborators of Brian A. Lanman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian A. Lanman. Brian A. Lanman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nalawansha, Dhanusha A., Kate S. Ashton, Weixian Deng, et al.. (2025). LYMTACs:chimeric small molecules repurpose lysosomal membrane proteins for target protein relocalization and degradation. Nature Communications. 16(1). 7812–7812. 2 indexed citations
2.
Zhu, Kai, et al.. (2022). Modeling receptor flexibility in the structure-based design of KRASG12C inhibitors. Journal of Computer-Aided Molecular Design. 36(8). 591–604. 8 indexed citations
3.
Saiki, Anne Y., Deanna Mohn, Yu Li, et al.. (2021). Abstract 1285: In vitro characterization of sotorasib and other RAS ‘His95-groove' binders and investigation of resistance mechanisms. Cancer Research. 81(13_Supplement). 1285–1285. 3 indexed citations
4.
Reed, Anthony B., Brian A. Lanman, Jerry Ryan Holder, et al.. (2020). Half-life extension of peptidic APJ agonists by N-terminal lipid conjugation. Bioorganic & Medicinal Chemistry Letters. 30(21). 127499–127499. 8 indexed citations
5.
Saiki, Anne Y., Kevin Gaida, Karen Rex, et al.. (2019). Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRASG12C. 4484–4484. 1 indexed citations
6.
7.
Rex, Karen, Anne Y. Saiki, Ji-Rong Sun, et al.. (2019). Abstract 3090: In vivo characterization of AMG 510 - a potent and selective KRASG12Ccovalent small molecule inhibitor in preclinical KRASG12Ccancer models. Cancer Research. 79(13_Supplement). 3090–3090. 6 indexed citations
8.
Saiki, Anne Y., Kevin Gaida, Karen Rex, et al.. (2019). Abstract 4484: Discovery and in vitro characterization of AMG 510–a potent and selective covalent small-molecule inhibitor of KRASG12C. Cancer Research. 79(13_Supplement). 4484–4484. 13 indexed citations
9.
Wu, Bin, Huiling Wang, Victor J. Cee, et al.. (2015). Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(4). 775–780. 20 indexed citations
10.
Wang, Huiling, Victor J. Cee, Brian A. Lanman, et al.. (2014). The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(4). 834–840. 27 indexed citations
11.
Lanman, Brian A., Anthony B. Reed, Victor J. Cee, et al.. (2014). Phosphoinositide-3-kinase inhibitors: Evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511. Bioorganic & Medicinal Chemistry Letters. 24(24). 5630–5634. 3 indexed citations
12.
Frohn, Mike, Victor J. Cee, Brian A. Lanman, et al.. (2011). Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: Potent S1P1 agonists with in vivo lymphocyte-depleting activity. Bioorganic & Medicinal Chemistry Letters. 22(1). 628–633. 9 indexed citations
13.
Reed, Anthony B., Brian A. Lanman, Susana Neira, et al.. (2011). Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groups. Bioorganic & Medicinal Chemistry Letters. 22(4). 1779–1783. 5 indexed citations
14.
Harrington, Paul E., Christopher Fotsch, Mike Frohn, et al.. (2011). Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. ACS Medicinal Chemistry Letters. 3(1). 74–78. 13 indexed citations
15.
Lanman, Brian A., et al.. (2007). On the Structure of Palau'amine:  Evidence for the Revised Relative Configuration from Chemical Synthesis. Journal of the American Chemical Society. 129(42). 12896–12900. 67 indexed citations
16.
Overman, Larry E. & Brian A. Lanman. (2006). Evaluation of Strategies for the Synthesis of the Guanidine Hemiaminal Portion of Palau’amine. Heterocycles. 70(1). 557–557. 22 indexed citations
17.
Lanman, Brian A. & Andrew G. Myers. (2004). Efficient, Stereoselective Synthesis of trans‐2,5‐Disubstituted Morpholines.. ChemInform. 35(31). 1 indexed citations
18.
Myers, Andrew G. & Brian A. Lanman. (2002). A Solid-Supported, Enantioselective Synthesis Suitable for the Rapid Preparation of Large Numbers of Diverse Structural Analogues of (−)-Saframycin A. Journal of the American Chemical Society. 124(44). 12969–12971. 49 indexed citations
19.
Myers, Andrew G., Boyu Zhong, Daniel W. Kung, et al.. (2000). Synthesis of C-Protected α-Amino Aldehydes of High Enantiomeric Excess from Highly Epimerizable N-Protected α-Amino Aldehydes. Organic Letters. 2(21). 3337–3340. 23 indexed citations
20.
Myers, Andrew G., Boyu Zhong, Mohammad Movassaghi, et al.. (2000). Synthesis of highly epimerizable N-protected α-amino aldehydes of high enantiomeric excess. Tetrahedron Letters. 41(9). 1359–1362. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Renhowe Breakdown of academic impact, for papers by Stephen T. Wrobleski Breakdown of academic impact, for papers by Michaël Prakesch Breakdown of academic impact, for papers by Les A. Dakin Breakdown of academic impact, for papers by Ana Belén Garcı́a Breakdown of academic impact, for papers by Tina M. Morwick Breakdown of academic impact, for papers by Darin J. Gustin Breakdown of academic impact, for papers by Naresh K. Chadha Breakdown of academic impact, for papers by Matthew A. Marx Breakdown of academic impact, for papers by Hong-Yong Kim
Rankless by CCL
2026